Physician profile
Terry Smith
NPI 1508952292
$16,960.48
in general payments reported to CMS, 2019-2025
32 companies · $3,246 in 2025
The $3,246 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,141 · 2022: $4,062 · 2023: $4,160 · 2024: $3,352 · 2025: $3,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,420.04 |
| Education | $337.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $4,299.86 | 2021-2025 | Enbrel, Otezla, Tavneos |
| Janssen Biotech, INC. | $1,682.83 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Abbvie INC. | $1,658.21 | 2021-2025 | |
| Ucb, INC. | $1,498.53 | 2021-2025 | Cimzia, Bimzelx |
| Lilly USA, LLC | $1,180.69 | 2021-2024 | Taltz, Zepbound |
| Mallinckrodt Hospital Products INC. | $1,055.88 | 2021-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $1,011.30 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $855.82 | 2021-2025 | Saphnelo |
| Glaxosmithkline, LLC. | $565.73 | 2021-2025 | Benlysta |
| Pfizer INC. | $471.42 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $466.18 | 2021-2025 | Orencia |
| Janssen Scientific Affairs, LLC | $457.89 | 2022-2025 | Tremfya |
| Horizon Therapeutics Plc | $336.70 | 2022-2023 | Krystexxa |
| Radius Health, INC. | $255.62 | 2021-2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.42 | 2021-2023 | Ofev |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $141.67 | 2023-2025 | Idacio |
| Genzyme Corporation | $133.68 | 2023-2025 | |
| Siemens Medical Solutions USA, INC. | $93.84 | 2024 | Sensis |
| Almatica Pharma LLC | $88.88 | 2024-2025 | Teriparatide |
| Aurinia Pharma U.S., INC. | $73.39 | 2022-2023 | Lupkynis |
| Neurometrix INC | $54.30 | 2023 | |
| Sandoz INC. | $49.61 | 2023-2025 | Jubbonti, Hyrimoz |
| Fidia Pharma USA INC. | $46.38 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $41.10 | 2024 | |
| Sobi, INC | $37.99 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $37.44 | 2022-2025 | Purified Cortrophin Gel |
| Alvogen INC | $30.53 | 2022 | |
| Pacira Therapeutics, INC. | $30.16 | 2021 | |
| Alexion Pharmaceuticals, INC. | $24.32 | 2025 | Strensiq |
| Biocon Biologics INC | $23.79 | 2025 | Yesintek |
| Cumberland Pharmaceuticals, INC. | $19.41 | 2022 | |
| Organon LLC | $17.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.